HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xinyi Jiang Selected Research

Messenger RNA (mRNA)

1/2024mRNA-Laden Lipid-Nanoparticle-Enabled in Situ CAR-Macrophage Engineering for the Eradication of Multidrug-Resistant Bacteria in a Sepsis Mouse Model.
1/2023Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy.
4/2022Inhaled mRNA Nanoformulation with Biogenic Ribosomal Protein Reverses Established Pulmonary Fibrosis in a Bleomycin-Induced Murine Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xinyi Jiang Research Topics

Disease

38Neoplasms (Cancer)
05/2024 - 12/2010
12Glioblastoma (Glioblastoma Multiforme)
03/2024 - 12/2010
11Glioma (Gliomas)
03/2024 - 06/2011
10Infections
01/2024 - 01/2018
7Inflammation (Inflammations)
01/2024 - 01/2016
7Breast Neoplasms (Breast Cancer)
01/2023 - 01/2016
5Hepatitis B
12/2022 - 01/2021
4Brain Neoplasms (Brain Tumor)
06/2023 - 01/2017
4Hepatocellular Carcinoma (Hepatoma)
01/2023 - 11/2020
4Fibrosis (Cirrhosis)
01/2023 - 01/2021
4Substance-Related Disorders (Drug Abuse)
12/2021 - 01/2021
4Virus Diseases (Viral Diseases)
10/2021 - 01/2018
3Liver Neoplasms (Liver Cancer)
03/2024 - 06/2013
3Acute Kidney Injury (Acute Renal Failure)
01/2024 - 01/2022
3Heart Failure
01/2022 - 12/2019
3Edema (Dropsy)
01/2022 - 12/2019
3Chronic Hepatitis C
10/2021 - 01/2021
3Osteolysis
01/2017 - 01/2016
2Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 01/2023
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2024 - 02/2022
2Reperfusion Injury
01/2024 - 02/2022
2Body Weight (Weight, Body)
12/2023 - 08/2011
2Hepatitis C
12/2023 - 01/2023
2Neoplasm Metastasis (Metastasis)
06/2023 - 01/2023
2Hypertension (High Blood Pressure)
01/2022 - 12/2019
2Liver Diseases (Liver Disease)
01/2021 - 06/2020
2Chronic Obstructive Pulmonary Disease (COPD)
10/2020 - 01/2018
1Autolysis
05/2024
1Sepsis (Septicemia)
01/2024
1Glaucoma
01/2024
1Infarction (Infarctions)
01/2024
1Brain Ischemia (Cerebral Ischemia)
01/2024
1Ischemic Stroke
01/2024
1Atrophy
12/2023
1Cachexia
12/2023
1Syphilis
06/2023
1Autoimmune Diseases (Autoimmune Disease)
03/2023
1Multiple Sclerosis
03/2023

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
04/2024 - 06/2011
10Paclitaxel (Taxol)FDA LinkGeneric
05/2014 - 12/2010
8HydrogelsIBA
12/2023 - 01/2017
7Antiviral Agents (Antivirals)IBA
12/2023 - 01/2021
6polytrimethylene carbonateIBA
05/2014 - 11/2011
5Ethylene Glycol (Monoethylene Glycol)IBA
01/2021 - 12/2010
4Indicators and Reagents (Reagents)IBA
03/2024 - 01/2018
4Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2022 - 01/2021
3Messenger RNA (mRNA)IBA
01/2024 - 04/2022
3DNA (Deoxyribonucleic Acid)IBA
02/2023 - 01/2018
3Liposomes (Liposome)IBA
01/2023 - 06/2013
3Immune Checkpoint InhibitorsIBA
10/2022 - 02/2020
3Peptides (Polypeptides)IBA
03/2022 - 12/2011
3Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
01/2022 - 12/2019
3Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2022 - 12/2019
3IntegrinsIBA
04/2013 - 12/2011
3cyclic arginine-glycine-aspartic acid peptideIBA
04/2013 - 12/2011
2NanocapsulesIBA
05/2024 - 03/2023
2AntigensIBA
04/2024 - 01/2020
2Immunoglobulin G (IgG)IBA
04/2024 - 01/2022
2RNA (Ribonucleic Acid)IBA
01/2024 - 01/2016
2Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2023
2Antimicrobial PeptidesIBA
01/2024 - 01/2023
2Chimeric Antigen ReceptorsIBA
02/2023 - 01/2023
2Small Interfering RNA (siRNA)IBA
01/2023 - 01/2020
2Urea (Carbamide)FDA LinkGeneric
01/2023 - 08/2011
2AntioxidantsIBA
12/2022 - 01/2019
21,4-dihydropyridine (dihydropyridine)IBA
01/2022 - 12/2019
2Matrix Metalloproteinases (MMPs)IBA
01/2021 - 01/2017
2EnzymesIBA
01/2019 - 01/2018
2ChemokinesIBA
01/2018 - 01/2017
2Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
05/2014 - 01/2014
2Antineoplastic Agents (Antineoplastics)IBA
02/2013 - 01/2013
2LDL Receptors (LDL Receptor)IBA
11/2012 - 06/2011
2caprolactoneIBA
06/2011 - 12/2010
1antiglomerular basement membrane antibodyIBA
05/2024
1Single-Domain AntibodiesIBA
04/2024
1Temozolomide (Temodar)FDA LinkGeneric
03/2024
1Lipid NanoparticlesIBA
01/2024
1AlbuminsIBA
01/2024
1Fibrinogen (Factor I)FDA Link
01/2024
1pterostilbeneIBA
01/2024
1ResveratrolIBA
01/2024
1CholesterolIBA
12/2023
1O-(glucuronic acid 2- sulfate)- (1- - 4)- O- (2,5)- anhydromannitol 6-sulfateIBA
12/2023
1Transcription Factors (Transcription Factor)IBA
12/2023
1IndolesIBA
11/2023
1Tryptophan (L-Tryptophan)FDA Link
11/2023
1indole-3-carbaldehydeIBA
11/2023
1Metal-Organic FrameworksIBA
06/2023
1CopperIBA
06/2023
1Sirtuin 1IBA
04/2023
1A-factor (Streptomyces)IBA
01/2023
1AmmoniaIBA
01/2023
1Ligases (Synthetase)IBA
01/2023
1Trastuzumab (Herceptin)FDA Link
01/2023

Therapy/Procedure

15Therapeutics
06/2023 - 06/2011
7Immunotherapy
12/2023 - 02/2020
5Drug Therapy (Chemotherapy)
03/2024 - 02/2013
3Replacement Arthroplasty
01/2017 - 01/2016
2Oral Administration
01/2022 - 05/2013
1High-Protein Diet
01/2023